News

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.
For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...
Limited edition Meta Quest 3S Xbox bundle features custom Xbox-themed headset and controllers, offering cloud gaming as part ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved ...
As GLP-1 drugs like Wegovy and Ozempic grow in popularity, so too has a kind of alternative: compounded versions of the drugs ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
More than 20 million people globally are injecting themselves with GLP-1s... Weight-loss pills will only see that explode ...
These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.